Meningococcal Vaccines Market Size, Trends, Share, Growth, and Regional Forecast, 2025 to 2032

Meningococcal Vaccines Market by Product (Meningococcal Polysaccharide Vaccine, Meningococcal Conjugate Vaccine, Serogroup B Meningococcal Vaccine), Age Group, Distribution Channel and Regional Analysis from 2025 to 2032

ID: PMRREP3640| 187 Pages | 11 Nov 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Meningococcal Vaccines Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Product Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. Pipeline Analysis
    6. PESTLE Analysis
    7. Porter’s Five Force Analysis
  4. Global Meningococcal Vaccines Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
    3. Global Meningococcal Vaccines Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
        1. Meningococcal Polysaccharide Vaccine
        2. Meningococcal Conjugate Vaccine
        3. Serogroup B Meningococcal Vaccine
      4. Market Attractiveness Analysis: Product
    4. Global Meningococcal Vaccines Market Outlook: Age Group
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Age Group, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
        1. Infants (0-24 months)
        2. Children (2-12 years)
        3. Adolescents and Young Adults
        4. Adults
      4. Market Attractiveness Analysis: Age Group
    5. Global Meningococcal Vaccines Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
  5. Global Meningococcal Vaccines Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Meningococcal Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product
      3. By Age Group
      4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
      1. Meningococcal Polysaccharide Vaccine
      2. Meningococcal Conjugate Vaccine
      3. Serogroup B Meningococcal Vaccine
    5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
      1. Infants (0-24 months)
      2. Children (2-12 years)
      3. Adolescents and Young Adults
      4. Adults
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  7. Europe Meningococcal Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product
      3. By Age Group
      4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
      1. Meningococcal Polysaccharide Vaccine
      2. Meningococcal Conjugate Vaccine
      3. Serogroup B Meningococcal Vaccine
    5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
      1. Infants (0-24 months)
      2. Children (2-12 years)
      3. Adolescents and Young Adults
      4. Adults
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  8. East Asia Meningococcal Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product
      3. By Age Group
      4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
      1. Meningococcal Polysaccharide Vaccine
      2. Meningococcal Conjugate Vaccine
      3. Serogroup B Meningococcal Vaccine
    5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
      1. Infants (0-24 months)
      2. Children (2-12 years)
      3. Adolescents and Young Adults
      4. Adults
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  9. South Asia & Oceania Meningococcal Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product
      3. By Age Group
      4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
      1. Meningococcal Polysaccharide Vaccine
      2. Meningococcal Conjugate Vaccine
      3. Serogroup B Meningococcal Vaccine
    5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
      1. Infants (0-24 months)
      2. Children (2-12 years)
      3. Adolescents and Young Adults
      4. Adults
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  10. Latin America Meningococcal Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product
      3. By Age Group
      4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
      1. Meningococcal Polysaccharide Vaccine
      2. Meningococcal Conjugate Vaccine
      3. Serogroup B Meningococcal Vaccine
    5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
      1. Infants (0-24 months)
      2. Children (2-12 years)
      3. Adolescents and Young Adults
      4. Adults
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  11. Middle East & Africa Meningococcal Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product
      3. By Age Group
      4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
      1. Meningococcal Polysaccharide Vaccine
      2. Meningococcal Conjugate Vaccine
      3. Serogroup B Meningococcal Vaccine
    5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
      1. Infants (0-24 months)
      2. Children (2-12 years)
      3. Adolescents and Young Adults
      4. Adults
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    7. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Pfizer Inc.
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. GSK
      3. Serum Institute of India Pvt. Ltd
      4. Sanofi Pasteur Inc.
      5. CansinoBl0
      6. BIO-MED
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate